Core Insights - Endava plc reported mixed results for the first quarter, with adjusted earnings of 20 cents per share, surpassing market estimates of 8 cents per share, while quarterly sales were $240.314 million, below expectations of $245.910 million [1] - The company anticipates second-quarter adjusted earnings between 20 cents to 23 cents per share, with sales projected between $241.410 million to $245.456 million [1] Financial Performance - The first quarter results were impacted by an unexpected credit to a client and certain strategic pipeline opportunities that did not convert into revenue as expected [2] - Despite these challenges, the company secured a multi-year strategic relationship with a leading payments company worth up to $100 million, indicating strong client relationships [2] Stock Performance and Analyst Ratings - Following the earnings announcement, Endava shares increased by 2.2%, trading at $7.10 [3] - Analysts adjusted their price targets for Endava, with Needham maintaining a Buy rating and lowering the target from $12 to $9, Guggenheim also maintaining a Buy rating with a target reduction from $18 to $15, and JP Morgan maintaining a Neutral rating with a target cut from $13 to $10 [5]

Core Insights - Mondelez International reported Q2 earnings of 73 cents per share, exceeding analyst expectations of 68 cents per share [1] - The company achieved quarterly sales of $8.984 billion, surpassing the analyst consensus estimate of $8.831 billion [1] Financial Performance - The company experienced accelerated top-line growth in Q2 2025, driven by strong pricing execution in the chocolate segment and robust growth across most geographies [2] - Mondelez International affirmed a projected decline of 10% in FY2025 adjusted EPS on a constant currency basis [2] Stock Performance - Following the earnings announcement, Mondelez International shares fell by 4.8%, trading at $66.38 [3] - Analysts adjusted their price targets for Mondelez International after the earnings report [3] Analyst Ratings - Stifel analyst Matthew Smith maintained a Buy rating and raised the price target from $73 to $76 [8] - Piper Sandler analyst Michael Lavery maintained a Neutral rating and increased the price target from $66 to $67 [8] - Bernstein analyst Alexia Howard maintained an Outperform rating and raised the price target from $79 to $88 [8]